Arkolith/Insider Trading/CTXR/Form 4

Mazur Leonard L

Chief Executive Officer, Director, 10% OwnerCitius Pharmaceuticals, Inc. (CTXR) · full profile →Form 4 · filed Sep 27, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
0 non-derivative · 4 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 25, 2024Disposed to issuer(D)2.2M——0
Sep 25, 2024Grant(A)2.2M——2.2M
Aug 14, 2024Disposed to issuer(D)3.1M——0
Aug 14, 2024Grant(A)3.1M——3.1M

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-24-082812) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML